| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,547 |
2,317 |
$253K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,997 |
1,761 |
$134K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
650 |
614 |
$89K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
785 |
715 |
$70K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
247 |
198 |
$30K |
| 99051 |
|
1,700 |
1,582 |
$22K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
432 |
345 |
$14K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
2,694 |
2,437 |
$6K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
25 |
20 |
$6K |
| 87481 |
|
97 |
77 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
25 |
25 |
$2K |
| 99072 |
|
498 |
396 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
29 |
23 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
214 |
188 |
$683.64 |
| 87640 |
|
34 |
25 |
$589.45 |
| 87529 |
|
12 |
12 |
$554.36 |
| 90674 |
|
17 |
17 |
$544.26 |
| 87581 |
|
29 |
22 |
$484.19 |
| 87486 |
|
29 |
22 |
$484.19 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
17 |
15 |
$417.53 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
29 |
23 |
$380.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
22 |
20 |
$307.16 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$277.18 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12 |
12 |
$277.18 |
| 87563 |
|
12 |
12 |
$277.18 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
48 |
44 |
$212.54 |
| 80053 |
Comprehensive metabolic panel |
30 |
28 |
$177.88 |
| 81003 |
|
76 |
72 |
$108.75 |
| 99000 |
|
111 |
106 |
$4.33 |
| 3044F |
|
13 |
12 |
$0.00 |
| 3046F |
|
13 |
12 |
$0.00 |